Form 8-K - Current report:
SEC Accession No. 0001140361-25-004806
Filing Date
2025-02-14
Accepted
2025-02-14 16:18:18
Documents
14
Period of Report
2025-02-12
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ef20043682_8k.htm   iXBRL 8-K 29900
2 EXHIBIT 10.1 ef20043682_ex10-1.htm EX-10.1 81946
  Complete submission text file 0001140361-25-004806.txt   262947

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA bcpc-20250212.xsd EX-101.SCH 3979
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE bcpc-20250212_lab.xml EX-101.LAB 21966
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bcpc-20250212_pre.xml EX-101.PRE 16042
16 EXTRACTED XBRL INSTANCE DOCUMENT ef20043682_8k_htm.xml XML 4056
Mailing Address 5 PARAGON DRIVE MONTVALE NJ 07645
Business Address 5 PARAGON DRIVE MONTVALE NJ 07645 (845) 326-5600
BALCHEM CORP (Filer) CIK: 0000009326 (see all company filings)

EIN.: 132578432 | State of Incorp.: MD | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-13648 | Film No.: 25629139
SIC: 2800 Chemicals & Allied Products
(CF Office: 08 Industrial Applications and Services)